Clinical Trial Update: Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004) [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports on the safety and preliminary efficacy of MK0759 for postherpetic neuralgia, with the study status listed as terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• MK0759

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Neuralgia, Postherpetic | Phase 2 | Status: TERMINATED